Depo-estradiol cypionate inj
Products billed under this code include Depo-Estradiol.
Payment limit per 5 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Depo-Estradiol.
Payment limit per 5 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Depo-Estradiol | Pfizer Inc | 00009-0271-01 | 5 | $269.025 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $53.805 | −$0.006 | 5 MG | Depo-estradiol cypionate inj | v1, posted September 17, 2026 |
| 3Q26 | $53.811 | +$1.991 | 5 MG | Depo-estradiol cypionate inj | v1, posted September 15, 2026 |
| 2Q26 | $51.82 | +$0.004 | 5 MG | Depo-estradiol cypionate inj | v1, posted September 15, 2026 |
| 1Q26 | $51.816 | +$2.538 | 5 MG | Depo-estradiol cypionate inj | v1, posted September 15, 2026 |
| 4Q25 | $49.278 | +$2.367 | 5 MG | Depo-estradiol cypionate inj | v1, posted September 8, 2026 |
| 3Q25 | $46.911 | +$4.588 | 5 MG | Depo-estradiol cypionate inj | v1, posted March 10, 2026 |
| 2Q25 | $42.323 | +$3.67 | 5 MG | Depo-estradiol cypionate inj | v1, posted March 10, 2026 |
| 1Q25 | $38.653 | $0.00 | 5 MG | Depo-estradiol cypionate inj | v1, posted December 19, 2025 |
| 4Q24 | $38.653 | −$0.677 | 5 MG | Depo-estradiol cypionate inj | v1, posted June 11, 2025 |
| 3Q24 | $39.33 | +$3.576 | 5 MG | Depo-estradiol cypionate inj | v1, posted June 11, 2025 |
| 2Q24 | $35.754 | $0.00 | 5 MG | Depo-estradiol cypionate inj | v1, posted March 11, 2025 |
| 1Q24 | $35.754 | +$3.085 | 5 MG | Depo-estradiol cypionate inj | v1, posted December 19, 2024 |
| 4Q23 | $32.669 | +$1.987 | 5 MG | Depo-estradiol cypionate inj | v1, posted October 10, 2024 |
| 3Q23 | $30.682 | +$1.433 | 5 MG | Depo-estradiol cypionate inj | v1, posted June 5, 2024 |
| 2Q23 | $29.249 | −$0.45 | 5 MG | Depo-estradiol cypionate inj | v1, posted February 23, 2024 |
| 1Q23 | $29.699 | +$3.245 | 5 MG | Depo-estradiol cypionate inj | v1, posted December 6, 2023 |
| 4Q22 | $26.454 | +$0.361 | 5 MG | Depo-estradiol cypionate inj | v1, posted June 22, 2023 |
| 3Q22 | $26.093 | +$2.175 | 5 MG | Depo-estradiol cypionate inj | v1, posted June 9, 2023 |
| 2Q22 | $23.918 | −$0.039 | 5 MG | Depo-estradiol cypionate inj | v1, posted December 14, 2022 |
| 1Q22 | $23.957 | −$0.023 | 5 MG | Depo-estradiol cypionate inj | v1, posted June 8, 2022 |
| 4Q21 | $23.98 | −$0.173 | 5 MG | Depo-estradiol cypionate inj | v1, posted June 2, 2022 |
| 3Q21 | $24.153 | +$0.106 | 5 MG | Depo-estradiol cypionate inj | v1, posted June 2, 2022 |
| 2Q21 | $24.047 | −$0.005 | 5 MG | Depo-estradiol cypionate inj | v1, posted March 1, 2022 |
| 1Q21 | $24.052 | – | 5 MG | Depo-estradiol cypionate inj | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.